These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16874553)

  • 1. A mathematical model for the regulation of tumor dormancy based on enzyme kinetics.
    Boushaba K; Levine HA; Nilsen-Hamilton M
    Bull Math Biol; 2006 Oct; 68(7):1495-526. PubMed ID: 16874553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor dormancy and role of microenvironment: a mathematical model.
    Kim Y; Boushaba K
    Adv Exp Med Biol; 2013; 734():237-59. PubMed ID: 23143982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microenvironment based model of antimitotic therapy of Gompertzian tumor growth.
    Kozusko F; Bourdeau M; Bajzer Z; Dingli D
    Bull Math Biol; 2007 Jul; 69(5):1691-708. PubMed ID: 17577604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-cell-based model of tumor growth in vitro: monolayers and spheroids.
    Drasdo D; Höhme S
    Phys Biol; 2005 Jul; 2(3):133-47. PubMed ID: 16224119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor dormancy of primary and secondary cancers.
    Udagawa T
    APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer.
    Eladdadi A; Isaacson D
    Bull Math Biol; 2008 Aug; 70(6):1707-29. PubMed ID: 18648887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A logistic cellular automaton for simulating tumor growth].
    Hu R; Ruan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):79-82. PubMed ID: 12744169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor dormancy and metastasis.
    Hedley BD; Chambers AF
    Adv Cancer Res; 2009; 102():67-101. PubMed ID: 19595307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator.
    Crippa MP
    Int J Biochem Cell Biol; 2007; 39(4):690-4. PubMed ID: 17118695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous growth inhibition of angiogenesis in brain tumors.
    Kirsch M; Allende R; Black P; Schackert G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):469-79. PubMed ID: 17960325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mathematical model of the morphogenesis of tumor nodules].
    Prokopchuk VS
    Arkh Patol; 1983; 45(1):55-61. PubMed ID: 6847402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.